Swipe om te navigeren naar een ander artikel
The aim of this study has been to evaluate the physical, psychological, and social well-being in a large group of Sardinian adult patients with transfusion-dependent beta-Thalassemia when compared with a group of healthy subjects of the same age and geographical extraction.
Male or female patients ≥ 18 years of age with Thalassemia major on regular transfusion at Thalassemia Center in Cagliari (Italy) were requested to complete the World Health Organization Quality of life-BREF (WHOQOL-BREF) questionnaire. The WHOQOL-BREF was also made available online to age- and sex-matched non-thalassemic adult subjects living in Sardinia.
Two hundred and seven subjects with Thalassemia were invited to participate in the study. The questionnaire was also completed by 211 age- and sex-matched non-thalassemic subjects living in Sardinia. Scores suggestive of a good quality of life were obtained in all the areas investigated. Thalassemia patients had scores at least as good as those of non-thalassemic subjects in all items and the percentage of those with a score ≥ 60 was higher among patients. The analysis of demographic actually highlights that the disease has a little effect on their personal and social lives. There was a positive association between subjective well-being and effective clinical conditions. Moreover, the association between health perception and adherence to treatment suggests that compliance with treatment contributes to the well-being of the patient, both physically and psychologically.
Adult subjects with Thalassemia who live in Western countries have a good quality of life in accordance with the advances in the management of the disease.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Cappellini, M. D., Cohen, A., Porter, J., Taher, A., & Viprakasit, V. (Eds.). (2014). Guidelines for the management of transfusion dependent Thalassaemia (TDT) [Internet] (3rd edn.). Nicosia (CY): Thalassaemia International Federation.
Sankaran, V. G., & Nathan, D. G. (2010). Thalassemia: an overview of 50 years of clinical research. Hematology/Oncology Clinics of North America 24(6), 1005–1020. https://doi.org/10.1016/j.hoc.2010.08.009. CrossRefPubMed
Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M. D., Del Vecchio, G. C., et al. (2004). Survival and complications in patients with Thalassemia major treated with transfusion and deferoxamine. Haematologica, 89(10), 1187–1193. PubMed
Modell, B., Khan, M., Darlison, M., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008). Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 10, 42. https://doi.org/10.1186/1532-429X-10-42. CrossRefPubMedPubMedCentral
Telfer, P., Coen, P. G., Christou, S., Hadjigavriel, M., Kolnakou, A., Pangalou, E., et al. (2006). Survival of medically treated Thalassemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematologica, 91(9), 1187–1192. PubMed
Origa, R., Piga, A., Quarta, G., Forni, G. L., Longo, F., Melpignano, A., et al. (2010). Pregnancy and beta-Thalassemia: An Italian multicenter experience. Haematologica, 95(3), 376–381. https://doi.org/10.3324/haematol.2009.012393. CrossRefPubMed
Bazi, A., Sargazi-Aval, O., Safa, A., & Miri-Moghaddam, E. (2017). Health-related quality of life and associated factors among Thalassemia major patients, Southeast of Iran. Journal of Pediatric Hematology/Oncology, 39(7), 513–517. https://doi.org/10.1097/MPH.0000000000000963. CrossRefPubMed
Tuysuz, G., & Tayfun, F. (2017). Health-related quality of life and its predictors among transfusion-dependent Thalassemia patients. Journal of Pediatric Hematology/Oncology, 39(5), 332–336. https://doi.org/10.1097/MPH.0000000000000790. CrossRefPubMed
Amid, A., Saliba, A. N., Taher, A. T., & Klaassen, R. J. (2015). Thalassaemia in children: From quality of care to quality of life. Archives of Disease in Childhood, 100(11), 1051–1057. https://doi.org/10.1136/archdischild-2014-308112. CrossRefPubMed
Gan, G. G., Hue, Y. L., & Sathar, J. (2016). Factors affecting quality of life in adult patients with Thalassaemia major and intermedia. Annals of the Academy of Medicine, Singapore, 45(11), 520–523. PubMed
The WHOQOL Group (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. CrossRef
WHO (1996). WHOQOL-BREF introduction, administration and scoring, field trial version. Geneva: World Health Organization.
Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., et al. (2005). MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent Thalassemia and sickle cell disease patients. Blood, 106(4), 1460–1465. https://doi.org/10.1182/blood-2004-10-3982. CrossRefPubMedPubMedCentral
Barbosa Silva, P. A., Soares, S. M., Guimarães Santos, G. F., & Barbosa Silva, L. (2014). Cut-off point for WHOQOL-bref as a measure of quality of life of older adults. Revista de saude publica, 48(3), 390–397. https://doi.org/10.1590/S0034-8910.2014048004912. CrossRef
Safizadeh, H., Farahmandinia, Z., Nejad, S. S., Pourdamghan, N., & Araste, M. (2012). Quality of life in patients with Thalassemia major and intermedia in kerman-iran (I.R.). Mediterranean Journal of Hematology and Infectious Diseases, 4(1), e2012058. https://doi.org/10.4084/MJHID.2012.058. CrossRefPubMedPubMedCentral
La Nasa, G., Caocci, G., Efficace, F., Dessì, C., Vacca, A., Piras, E., et al. (2013). Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for Thalassemia. Blood, 122(13), 2262–2270. https://doi.org/10.1182/blood-2013-05-502658. CrossRefPubMed
Haghpanah, S., Vahdati, S., & Karimi, M. (2017). Comparison of quality of life in patients with β-Thalassemia intermedia and β-Thalassemia major in Southern Iran. Hemoglobin, 41(3), 169–174. https://doi.org/10.1080/03630269.2017.1340307. CrossRefPubMed
Taher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., et al. (2010). Overview on practices in Thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: The OPTIMAL CARE study. Blood, 115(10), 1886–1892. https://doi.org/10.1182/blood-2009-09-243154. CrossRefPubMed
Amid, A., Leroux, R., Merelles-Pulcini, M., Yassobi, S., Saliba, A. N., Ward, R., Karimi, M.,., Taher, A. T., Klaassen, R. J., & Kirby-Allen, M. (2016). Factors impacting quality of life in Thalassemia patients; results from the Intercontinenthal Collaborative Study. Blood, 128, 3633.
Clouet, F., Excler-Cavailher, G., Christophe, B., Masson, F., & Fasquel, D. (2001). Type 2 diabetes and short form 36-items health survey. Diabetes & Metabolism, 27(6), 711–717.
WHO (2005). Constitution of the World Health Organization. In World Health Organization, Basic documents (45th edn). Geneva: World Health Organization.
- Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study
Maria Paola Pilia
Maria Rosaria Casini
- Springer International Publishing